1. Home
  2. NXL vs WKSP Comparison

NXL vs WKSP Comparison

Compare NXL & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • WKSP
  • Stock Information
  • Founded
  • NXL 2010
  • WKSP 2003
  • Country
  • NXL United States
  • WKSP United States
  • Employees
  • NXL N/A
  • WKSP N/A
  • Industry
  • NXL Medical Specialities
  • WKSP Auto Parts:O.E.M.
  • Sector
  • NXL Health Care
  • WKSP Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • WKSP Nasdaq
  • Market Cap
  • NXL 14.0M
  • WKSP 14.6M
  • IPO Year
  • NXL 2022
  • WKSP N/A
  • Fundamental
  • Price
  • NXL $0.84
  • WKSP $3.41
  • Analyst Decision
  • NXL Strong Buy
  • WKSP Strong Buy
  • Analyst Count
  • NXL 1
  • WKSP 3
  • Target Price
  • NXL $5.00
  • WKSP $12.83
  • AVG Volume (30 Days)
  • NXL 2.9M
  • WKSP 546.0K
  • Earning Date
  • NXL 08-06-2025
  • WKSP 08-13-2025
  • Dividend Yield
  • NXL N/A
  • WKSP N/A
  • EPS Growth
  • NXL N/A
  • WKSP N/A
  • EPS
  • NXL N/A
  • WKSP N/A
  • Revenue
  • NXL $174,813.00
  • WKSP $12,395,166.00
  • Revenue This Year
  • NXL $38.28
  • WKSP $163.94
  • Revenue Next Year
  • NXL $185.71
  • WKSP $78.39
  • P/E Ratio
  • NXL N/A
  • WKSP N/A
  • Revenue Growth
  • NXL 16.42
  • WKSP 232.13
  • 52 Week Low
  • NXL $0.59
  • WKSP $2.44
  • 52 Week High
  • NXL $4.49
  • WKSP $12.00
  • Technical
  • Relative Strength Index (RSI)
  • NXL 45.15
  • WKSP 52.12
  • Support Level
  • NXL $0.78
  • WKSP $3.01
  • Resistance Level
  • NXL $0.99
  • WKSP $4.30
  • Average True Range (ATR)
  • NXL 0.12
  • WKSP 0.33
  • MACD
  • NXL 0.01
  • WKSP 0.06
  • Stochastic Oscillator
  • NXL 25.40
  • WKSP 41.68

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: